Nasopharyngeal carcinoma

Common Name(s)

Nasopharyngeal carcinoma

Nasopharyngeal carcinoma (NPC, NPCA) is a multifactorial malignancy associated with both genetic and environmental factors. The cancer arises from the epithelium of the nasopharynx. The Epstein-Barr virus has been implicated ({12:Tse et al., 2009}). A susceptibility locus for nasopharyngeal carcinoma (NPCA1) has been mapped to chromosome 4p. A second locus, NPCA2 ({161550}), has been mapped to chromosome 6p21.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Nasopharyngeal carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Nasopharyngeal carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Nasopharyngeal carcinoma" returned 1184 free, full-text research articles on human participants. First 3 results:

Nasopharyngeal carcinoma presenting with rapidly progressive severe visual disturbance: a case report.
 

Author(s): Yoshinobu Kamio, Naoto Sakai, Goro Takahashi, Satoshi Baba, Hiroki Namba

Journal:

 

Nasopharyngeal carcinoma is one of the most difficult tumors to diagnose correctly at the initial phase because of the occasional lack of nasal symptoms. The perineural spread of the trigeminal nerve is one of the most common and important routes in the intracranial paracavernous ...

Last Updated: 12 Nov 2014

Go To URL
Nodal metastatic, undifferentiated nasopharyngeal carcinoma and classical Hodgkin lymphoma: age old mimics.
 

Author(s): Rekha A Nair, Priya M Jacob

Journal: Indian J Pathol Microbiol. ;57(3):507-9.

 

Last Updated: 14 Aug 2014

Go To URL
Clinical study of nasopharyngeal carcinoma treated by helical tomotherapy in China: 5-year outcomes.
 

Author(s): Lei Du, Xin-Xin Zhang, Lin Ma, Lin-Chun Feng, Fang Li, Gui-Xia Zhou, Bao-Lin Qu, Shou-Ping Xu, Chuan-Bin Xie, Jack Yang

Journal: Biomed Res Int. 2014 ;2014():980767.

 

To evaluate the outcomes of nasopharyngeal carcinoma (NPC) patients treated with helical tomotherapy (HT).

Last Updated: 12 Aug 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Nasopharyngeal carcinoma" returned 52 free, full-text review articles on human participants. First 3 results:

The Interleukin-18 promoter -607C>A polymorphism contributes to nasopharyngeal carcinoma risk: evidence from a meta-analysis including 1,886 subjects.
 

Author(s): Xu-Guang Guo, Yong Xia

Journal: Asian Pac. J. Cancer Prev.. 2013 ;14(12):7577-81.

 

The interleukin-18 promoter -607C>A gene polymorphism may be related to nasopharyngeal carcinoma (NPC) risk but the results of individual studies remain conflicting. A meta-analysis including 1,886 subjects from five individual studies was therefore performed to provide a more accurate ...

Last Updated: 27 Jan 2014

Go To URL
Involvement of EBV-encoded BART-miRNAs and dysregulated cellular miRNAs in nasopharyngeal carcinoma genesis.
 

Author(s): Yuan-Jie Xie, Zhi-Feng Long, Xiu-Sheng He

Journal: Asian Pac. J. Cancer Prev.. 2013 ;14(10):5637-44.

 

The definite molecular mechanisms underlying the genesis of nasopharyngeal carcinomas (NPCs) remain to be completely elucidated. miRNAs are small non-coding RNAs which are implicated in cell proliferation, apoptosis, and even carcinogenesis through negatively regulating gene expression ...

Last Updated: 2 Dec 2013

Go To URL
Current treatment options for local residual nasopharyngeal carcinoma.
 

Author(s): S D Stoker, J N A van Diessen, J P de Boer, B Karakullukcu, C R Leemans, I B Tan

Journal: Curr Treat Options Oncol. 2013 Dec;14(4):475-91.

 

Local residual disease occurs in 7-13 % after primary treatment for nasopharyngeal carcinoma (NPC). To prevent tumor progression and/or distant metastasis, treatment is indicated. Biopsy is the "gold standard" for diagnosing residual disease. Because late histological regression frequently ...

Last Updated: 27 Nov 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)
 

Status: Recruiting

Condition Summary: Recurrent Nasopharyngeal Carcinoma; Metastatic Nasopharyngeal Carcinoma

 

Last Updated: 8 Feb 2012

Go to URL
Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli
 

Status: Not yet recruiting

Condition Summary: Nasopharyngeal Carcinoma

 

Last Updated: 23 Jul 2014

Go to URL
Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis
 

Status: Recruiting

Condition Summary: Nasopharyngeal Carcinoma; Radiation Therapy Complication

 

Last Updated: 7 Feb 2014

Go to URL